AFC HD AMS Life Science 1Q Net Y522.00M Vs Net Y460.00M

Dow Jones01-14

    AFC-HD AMS Life Science Co. Ltd. (2927.TO) 
    Japan 
    1st Quarter Ended November 30 
GROUP                2025                 2024 
Revenue              Y8.55 bln       Y8.19 bln 
Operating Profit     Y771.00 mln   Y650.00 mln 
Pretax Profit        Y739.00 mln   Y704.00 mln 
Net Profit           Y522.00 mln   Y460.00 mln 
Per share 
  Earnings           Y36.70             Y32.70 
  Diluted Earnings   N/A                Y32.69 
 
    Results are based on Japanese accounting standards.

(END) Dow Jones Newswires

    AFC-HD AMS Life Science Co. Ltd. also released the following forecasts: 
GROUP              1st Half To 
                      Feb 2026 
Revenue             Y16.73 bln 
Operating Profit     Y1.30 bln 
Pretax Profit        Y1.33 bln 
Net Profit         Y883.00 mln 
Per share 
  Earnings              Y59.11 
 
    Results are based on Japanese accounting standards.

This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.

(END) Dow Jones Newswires

January 14, 2026 01:36 ET (06:36 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2603466238?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-14 14:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603466238","market":"sh","top_or_hot":-1,"title":"AFC HD AMS Life Science 1Q Net Y522.00M Vs Net Y460.00M","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    AFC-HD AMS Life Science Co. Ltd. (2927.TO) \n    Japan \n    1st Quarter Ended November 30 \nGROUP                2025                 2024 \nRevenue              Y8.55 bln       Y8.19 bln \nOperating Profit     Y771.00 mln   Y650.00 mln \nPretax Profit        Y739.00 mln   Y704.00 mln \nNet Profit           Y522.00 mln   Y460.00 mln \nPer share \n  Earnings           Y36.70             Y32.70 \n  Diluted Earnings   N/A                Y32.69 \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n</font><font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    AFC-HD AMS Life Science Co. Ltd. also released the following forecasts: \nGROUP              1st Half To \n                      Feb 2026 \nRevenue             Y16.73 bln \nOperating Profit     Y1.30 bln \nPretax Profit        Y1.33 bln \nNet Profit         Y883.00 mln \nPer share \n  Earnings              Y59.11 \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 14, 2026 01:36 ET (06:36 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AFC HD AMS Life Science 1Q Net Y522.00M Vs Net Y460.00M</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAFC HD AMS Life Science 1Q Net Y522.00M Vs Net Y460.00M\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2026-01-14 14:36</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n    AFC-HD AMS Life Science Co. Ltd. (2927.TO) \n    Japan \n    1st Quarter Ended November 30 \nGROUP                2025                 2024 \nRevenue              Y8.55 bln       Y8.19 bln \nOperating Profit     Y771.00 mln   Y650.00 mln \nPretax Profit        Y739.00 mln   Y704.00 mln \nNet Profit           Y522.00 mln   Y460.00 mln \nPer share \n  Earnings           Y36.70             Y32.70 \n  Diluted Earnings   N/A                Y32.69 \n \n    Results are based on Japanese accounting standards. \n</pre>\n<p>\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n</p>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  January 14, 2026 01:36 ET (06:36 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU2361044949.HKD","symbol_name":"WELLINGTON US QUALITY GROWTH \"A\" (HKD) ACC","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2603466238","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2603466238","pubTimestamp":1768372560,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU2361044949.HKD":"WELLINGTON US QUALITY GROWTH \"A\" (HKD) ACC","LU2461242641.AUD":"WELLINGTON US QUALITY GROWTH \"A\" (AUDHDG) ACC","IE00B1XK9C88.USD":"PINEBRIDGE US LARGE CAP RESEARCH ENHANCED \"A\" (USD) ACC","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","BK6515":"技术设备股","BK4588":"碎股","LU0868494708.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) INC","LU1093756168.USD":"FRANKLIN K2 ALTERNATIVE STRATEGIES \"A\" (USD) ACC","BK4196":"保健护理服务","LU1929549753.HKD":"FRANKLIN INCOME \"A\" (HKD) INC","LU1236620750.USD":"HSBC GIF GLOBAL SUSTAINABLE LONG TERM DIVIDEND \"AM2\" (USD) INC","LU0943347566.SGD":"安联收益及增长平衡基金AM H2-SGD","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","IE00BSNM7G36.USD":"NEUBERGER BERMAN SYSTEMATIC GLOBAL SUSTAINABLE VALUE \"A\" (USD) ACC","BK4581":"高盛持仓","LU0820562030.AUD":"ALLIANZ INCOME AND GROWTH \"AMH2\" (AUDHDG) H2 INC","LU0823434583.USD":"BNP PARIBAS US GROWTH \"C\" (USD) ACC","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC","HD":"家得宝","LU1069344957.HKD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (HKD) INC","BK4550":"红杉资本持仓","LU0354030511.USD":"ALLSPRING  U.S. LARGE CAP GROWTH \"I\" (USD) ACC","LU0823434740.USD":"BNP PARIBAS US GROWTH \"C\" (USD) INC","BK4567":"ESG概念","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","LU1989772840.SGD":"CPR Invest - Climate Action A2 Acc SGD-H","LU0354030438.USD":"富国美国大盘成长基金Cl A Acc","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU1551013425.SGD":"Allianz Income and Growth Cl AMg2 DIS H2-SGD","LU1496350171.SGD":"FRANKLIN DIVERSIFIED BALANCED \"A\" (SGDHDG) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","BK6062":"电子制造服务","LU1035775433.USD":"AB SICAV I - AMERICAN GROWTH PORTFOLIO \"AD\" (USD) INC","LU1496350502.SGD":"FRANKLIN DIVERSIFIED DYNAMIC \"A\" (SGDHDG) ACC","LU2756315318.SGD":"ALLIANZ INCOME AND GROWTH \"AMG\" (SGDHDG) INC A","BK4566":"资本集团","BK4083":"家庭装潢零售","LU1674673691.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (USD) INC","LU0234572021.USD":"高盛美国核心股票组合Acc","AMS":"American Shared Hospital Services","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","BK4504":"桥水持仓","LU0238689110.USD":"贝莱德环球动力股票基金","LU0320765646.SGD":"FTIF - Franklin Income A MDIS SGD-H1","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU0942090050.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD)  INC","LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","LU0823411888.USD":"法巴消费创新基金 Cap","M11.SI":"综合制造科技"},"translate_title":"AFC HD AMS生命科学第一季度净值Y522.00M Vs净值Y460.00M","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"M11.SI":1.5,"AMS":1.5,"HD":1.5},"content_text":"AFC-HD AMS Life Science Co. Ltd. (2927.TO) \n    Japan \n    1st Quarter Ended November 30 \nGROUP                2025                 2024 \nRevenue              Y8.55 bln       Y8.19 bln \nOperating Profit     Y771.00 mln   Y650.00 mln \nPretax Profit        Y739.00 mln   Y704.00 mln \nNet Profit           Y522.00 mln   Y460.00 mln \nPer share \n  Earnings           Y36.70             Y32.70 \n  Diluted Earnings   N/A                Y32.69 \n \n    Results are based on Japanese accounting standards. \n\n\n  (END) Dow Jones Newswires\n\n\n\n    AFC-HD AMS Life Science Co. Ltd. also released the following forecasts: \nGROUP              1st Half To \n                      Feb 2026 \nRevenue             Y16.73 bln \nOperating Profit     Y1.30 bln \nPretax Profit        Y1.33 bln \nNet Profit         Y883.00 mln \nPer share \n  Earnings              Y59.11 \n \n    Results are based on Japanese accounting standards. \n\n\n     This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com. \n\n\n  (END) Dow Jones Newswires\n\n\n  January 14, 2026 01:36 ET (06:36 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603466238","isCrawlerRequest":true}